| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | THE UNITED STATES PHARMACOPEIAL CONVENTION, INC. | 12601 TWINBROOK PKWY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | U01FD007762 | Assessment of the performance of MAM vs conventional QC methods for evaluation of Product Quality Attributes of adalimumab and etanercept | 001 | 1 | FDA | 6/25/2024 | $0 |
| | 2024 | 2022 | THE UNITED STATES PHARMACOPEIAL CONVENTION, INC. | 12601 TWINBROOK PKWY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331883 | Medicare Model Guidelines (MMG) Version 9.0 | 01 | 1 | CMS | 4/16/2024 | $0 |
| | 2024 | 2022 | THE UNITED STATES PHARMACOPEIAL CONVENTION, INC. | 12601 TWINBROOK PKWY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | U01FD007762 | Assessment of the performance of MAM vs conventional QC methods for evaluation of Product Quality Attributes of adalimumab and etanercept | 000 | 1 | FDA | 3/27/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,630,721 ) |
| | 2022 | 2022 | UNITED STATES PHARMACOPEIAL CONVENTION, INC., THE | 12601 Twinbrook Pkwy | Rockville | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331883 | Medicare Model Guidelines (MMG) Version 9.0 | 00 | 1 | CMS | 9/26/2022 | $100,000 |
| | 2022 | 2022 | UNITED STATES PHARMACOPEIAL CONVENTION, INC., THE | 12601 TWINBROOK PKWY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | U01FD007762 | Assessment of the performance of MAM vs conventional QC methods for evaluation of Product Quality Attributes of adalimumab and etanercept | 000 | 1 | FDA | 8/24/2022 | $1,530,721 |
|
| Issue Date FY: 2021 ( Subtotal = -$29,007 ) |
| | 2021 | 2019 | United States Pharmacopeial Convention, Inc., The | 12601 Twinbrook Pkwy | Rockville | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331728 | Medicare Model Guidelines Version 8 | 02 | 1 | CMS | 12/10/2020 | -$29,007 |
|
| Issue Date FY: 2019 ( Subtotal = $100,000 ) |
| | 2019 | 2019 | United States Pharmacopeial Convention, Inc., The | 12601 Twinbrook Pkwy | Rockville | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331728 | Medicare Model Guidelines Version 8 | 01 | 1 | CMS | 8/8/2019 | $0 |
| | 2019 | 2019 | United States Pharmacopeial Convention, Inc., The | 12601 Twinbrook Pkwy | Rockville | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331728 | Medicare Model Guidelines Version 8 | 00 | 1 | CMS | 7/19/2019 | $100,000 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | United States Pharmacopeial Convention, Inc., The | 12601 Twinbrook Pkwy | Rockville | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331494 | Complete The USP Medicare Model Guidelines v7.0 as stipulated in Section 1860 D-4 (b)(3)(C)(ii) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 | 01 | 1 | CMS | 10/4/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $100,000 ) |
| | 2016 | 2016 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331494 | Complete The USP Medicare Model Guidelines v7.0 as stipulated in Section 1860 D-4 (b)(3)(C)(ii) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 | 00 | 1 | CMS | 4/20/2016 | $100,000 |
|
| Issue Date FY: 2015 ( Subtotal = -$23,171 ) |
| | 2015 | 2013 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331232 | USP 2013 | 01 | 1 | CMS | 10/28/2014 | -$23,171 |
|
| Issue Date FY: 2013 ( Subtotal = -$128,448 ) |
| | 2013 | 2013 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS331232 | USP 2013 | 00 | 1 | CMS | 7/16/2013 | $100,000 |
| | 2013 | 2010 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS330738 | CONGRESSIONAL EARMARK: VERSION 5 COMPLETION OF THE MODEL GUIDELINES | 01 | 1 | CMS | 1/7/2013 | -$228,448 |
|
| Issue Date FY: 2010 ( Subtotal = $500,000 ) |
| | 2010 | 2010 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852-1717 | MONTGOMERY | USA | 1C0CMS330738 | CONGRESSIONAL EARMARK: VERSION 5 COMPLETION OF THE MODEL GUIDELINES | 00 | 1 | CMS | 7/13/2010 | $500,000 |
|
| Issue Date FY: 2007 ( Subtotal = $450,000 ) |
| | 2007 | 2007 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 1C0CMS300043 | MAINTENANCE OF DRUG CLASSES AND CATEGORIES IN PART D | 0 | 3 | CMS | 5/9/2007 | $450,000 |
| | 2007 | 2007 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 1C0CMS300043 | MAINTENANCE OF DRUG CLASSES AND CATEGORIES IN PART D | 1 | 3 | CMS | 5/24/2007 | $450,000 |
| | 2007 | 2007 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 1C0CMS300043 | MAINTENANCE OF DRUG CLASSES AND CATEGORIES IN PART D | 2 | 3 | CMS | 6/1/2007 | -$450,000 |
|
| Issue Date FY: 2006 ( Subtotal = $523,752 ) |
| | 2006 | 2006 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | R13 HS16515 | MEDICATION ERROR REPORTING SYSTEMS: CHALLENGES, LESSONS, FUTURE DIRECTION | 000 | 01 | AHRQ | 8/25/2006 | $49,000 |
| | 2006 | 2006 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 1C0CMS300043 | MAINTENANCE OF DRUG CLASSES AND CATEGORIES IN PART D | 0 | 2 | CMS | 6/22/2006 | $474,752 |
|
| Issue Date FY: 2005 ( Subtotal = $600,000 ) |
| | 2005 | 2005 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 1C0CMS300043 | MAINTENANCE OF DRUG CLASSES AND CATEGORIES IN PART D | 0 | 1 | CMS | 9/19/2005 | $600,000 |
|
| Issue Date FY: 2004 ( Subtotal = $1,150,442 ) |
| | 2004 | 0 | UNITED STATES PHARMACOPEIA | 12601 TWINBROOKE PARKWAY | ROCKVILLE | MD | 20852 | MONTGOMERY | USA | 92305 | DEVELOPMENT OF DRUG CLASSES AND CATEGORIES IN PART D | 0 | 01 | CMS | 6/8/2004 | $1,150,442 |
|
|
